YELENA KISEL: Open Payments
NPI 1619201654 · WORCESTER, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,941 in 228 payments from 21 companies in 2025. Trend: 2023 $5,926 · 2024 $6,252 · 2025 $4,941
Food & beverage: $4,771Education: $170
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 45 | $780 |
| UCB, Inc. | 30 | $747 |
| Janssen Biotech, Inc. | 21 | $601 |
| Galderma Laboratories, L.P. | 24 | $474 |
| Lilly USA, LLC | 15 | $358 |
| Arcutis Biotherapeutics, Inc. | 17 | $304 |
| Amgen Inc. | 9 | $289 |
| E.R. Squibb & Sons, L.L.C. | 13 | $205 |
| Regeneron Healthcare Solutions, Inc. | 8 | $189 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 9 | $177 |
Products named: Bimzelx, TREMFYA, SKYRIZI, NEMLUVIO, DUPIXENT, TALTZ, Zoryve, Otezla.
Industry payments across MA — which companies pay providers there.
